T. Rowe Price Investment Management »

Janux Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $24M 973k 24.44

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Meta Platforms Comm Stk (META)
Yum Brands Comm Stk (YUM)
Abbott Labs Comm Stk (ABT)
Alphabet Comm Stk (GOOGL)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Advanced Micro Devices Comm Stk (AMD)
Ameren Corp Comm Stk (AEE)

View all positions for T. Rowe Price Investment Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics